2016 MT-DIRC Fellow Shellie Ellis, MA, PhD was recently awarded an NIH P20 subproject titled Implementing Precision Medicine: Determinants of Adoption in Community Oncology.
It is a 3-year project to better understand precision medicine use and determinants of innovation adoption in oncology more broadly. 2014 MT-DIRC Fellow Sarah Birken, PhD is also contributing to this grant as a consultant.